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Dear participants, 
We are pleased to welcome you in Sofia, the capital of Bulgaria, for the 
second meeting of the European Network on Understanding Gastrointestinal 
Absorption-related Processes (UNGAP). We hope to sustain the high 
standards set by the first meeting in Leuven, Belgium, which was attended 
by more than 110 participants and included 19 lectures and 40+ posters by 
renowned experts. The scientific discussions that were initiated during the 
first meeting will continue in the framework of the four major challenges that 
UNGAP aims to address in the different working groups (WGs): differences 
between specific patient populations (WG1), regional differences along the 
gastrointestinal tract (WG2), the intraluminal behaviour of advanced 
formulations (WG3), and the food-drug interface (WG4). Expert talks by 
UNGAP members and external invited scientists will provide insight into the 
latest advancements on the topics of interest, whereas separate work group 
sessions and poster presentations will offer a platform for focused 
discussions on specific problems. PhD students will have the opportunity to 
present their work and network with top experts in their field. These activities 
are aimed to stimulate the cross-field dissemination of knowledge and 
thereby advance our understanding of drug absorption in the gut. 
Keynote lectures relevant to WGs will take place in Vitosha hall on Tuesday 
(12th February) morning, followed by a light lunch in the poster area. The 
participants will then split into 4 groups for the parallel WG sessions (halls 
inside the hotel) and will reconvene in the afternoon for an all-WG discussion 
in Vitosha hall. The official conference dinner will be held in the restaurant of 
hotel Vitosha on Tuesday evening. On Wednesday (13th February), hot-topic 
presentations by all WGs will be presented in Vitosha hall. 
UNGAP would not have been possible without the support of the European 
Cooperation in Science and Technology (COST) program, for which we are 
very grateful. 
We hope that you will have fruitful discussions during the meeting and will 
enjoy your visit in Sofia! 
Welcome to Sofia and to the UNGAP community! 
The organizing committee 
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Tuesday, 12th February 
8:30 Registration 
9:00 Welcome 
9:15 – 12:30 Keynote lectures (All Work Groups) 
Vitosha hall, outside the Hotel 
12:30 – 14:00 Lunch & Poster session 
Vitosha hall, outside the Hotel 
14:00 – 16:00 Parallel Work Group sessions 
Halls inside the Hotel 
16:30 – 17:30 Pearls of Wisdom: discussion on “gastro-
retention doesn’t work?” 
Moderator: Prof. Clive Wilson 
Vitosha hall, outside the Hotel 
19:00 Official dinner, Vitosha Hotel Restaurant 
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Wednesday, 13th February 
Venue: Vitosha Hall (outside the Hotel) all day, all WGs 
8:30 – 10:00 WG1 meeting: How the differences in GI 
absorption of special populations impact the stages of drug 
product development 
Chair: Dr. Katarina Vucicevic 
10:15 – 11:45 WG2 meeting: Regional differences along the 
GI tract 
Chair: Prof. Maria Vertzoni 
11:45 – 12:45 Lunch & Poster session 
12:45 – 14:15 WG3 meeting: Intraluminal behaviour of 
advanced formulations 
Chair: Prof. Caitriona O'Driscoll 
14:30 – 16:00 WG4 meeting: Food-drug interface 
Chair: Prof. Maura Corsetti 
16:00 – 16:30 General discussion and Wrap up of meeting 
Prof. Christos Reppas 
Conference halls 
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Vitosha 
Conference Hall
 Tuesday (until noon) 
 Wednesday (whole day)
Hotel 
Entrance 
The main hall where most of the UNGAP meeting and events 
will take place is Vitosha Conference Hall. This hall is located 
in a building across the street, right next to the hotel (1-2 min 
walking distance). One can get there easily by exiting the hotel, 
turning right and walking to the building across the street, where 
Vitosha Conference Hall is located (see the map below). 
 
How to get there: Vitosha Hall location 
Conference halls 
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Conference rooms for the parallel WG sessions (Tuesday, 
12th February, after lunch) 
On Tuesday (12th February) after lunch, the parallel WG 
sessions will take place on the second floor of the Hotel, 
which can be accessed by stairs and elevator. Signs will 
indicate the location of the conference rooms inside the hotel. 
WG1 – Hall 233    WG3 – Hall 3                
WG2 – Hall 231   WG4 – Hall 2 
Detailed program of the meeting 
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Tuesday 12th February (morning session) 
Vitosha Conference Hall 
(outside the hotel) 
8:30 – 17:00 Registration 
9:00 – 9:15 Welcome and introduction 
Prof. Patrick Augustijns, Prof. Peter Kralchevsky 
9:15 – 10:00 
Effect of food structure on nutrients release and 
lipid digestion 
Dr. Myriam Grundy (Reading University; Infogest) 
10:00 – 10:45 
Administering oral drug products in specific 
populations 
Dr. Hannah Batchelor (School of Pharmacy, University 
of Birmingham) 
10:45 – 11:00 Coffee break 
11:00 – 11:45 
The challenges and opportunities of drug 
development for multimorbid patient populations 
Prof. Sven Stegemann (Graz University of Technology) 
11:45 – 12:30 
Challenges and future perspectives of amorphous 
solid dispersions 
Prof. Guy Van Den Mooter (University of Leuven) 
12:30 – 14:00 Light Lunch & poster session (Vitosha Hall) "Meet the expert" lunch for PhD students 
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Tuesday 12th February (afternoon session) 
Parallel WG sessions: 
WG1, Hall 233 
WG2, Hall 231
WG3, Hall 3 
WG4, Hall 2 
These halls are inside the hotel! 
14:00 – 14:05 Introduction by WG leads 
14:05 – 15:05 Presentations by PhD students; PYPOM session (WG1, WG2, WG3) 
15:05 – 15:35 
Small group discussions related to the WG future: 
 Best practices 
 Short-term scientific missions (STSMs) 
 Research collaborations 
 New project proposals 
15:35 – 15:50 Presentation of the results of the small group discussions 
15:50 – 16:00 Preparation of WG summary to be presented on Wednesday 
 
All-WG session 
Vitosha Hall, outside the hotel 
16:00 – 16:30 Coffee break 
16:30 – 17:30 
Pearls of Wisdom: discussion on “gastro-
retention doesn’t work?” 
Moderator: Prof. Clive Wilson 
19:00 Official dinner 
Vitosha Hotel Restaurant 
Detailed program of the meeting 
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Wednesday 13th February (morning session) 
All-WG session 
Vitosha Hall (outside the hotel) 
WG1 meeting: How the differences in GI absorption of 
special populations impact the stages of drug product development 
Chair: Dr Katarina Vucicevic 
8:30  – 10:00 
Beyond the pill: How the differences in GI 
absorption of special age populations impact the 
drug product design 
Dr Mine Orlu, School of Pharmacy - UCL 
Beyond the pill: How the differences in GI 
absorption of special age populations impact the 
drug exposure and response  
Dr Katarina Vucicevic, Faculty of Pharmacy, 
University of Belgrade 
Update on current and future WG activities 
10:00 – 10:15 Coffee break 
WG2 Meeting: Regional differences along the GI tract 
Chair: Prof. Maria Vertzoni 
10:15 – 11:45 
Physicochemical characteristics, viscosity, and 
volumes along the GI lumen of humans vs. dogs 
and the usefulness of canine data in the 
development of oral drug products for humans 
and for dogs 
Prof. Christos Reppas,  Faculty of pharmacy, 
University of Athens 
Regional intestinal permeability in humans: 
implications for modified-release dosage forms 
Dr. David Dahlgren, Uppsala University 
Update on current and future WG activities 
Detailed program of the meeting 
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Wednesday 13th February (afternoon session) 
11:45 – 12:45 Light Lunch & poster session "Meet the expert" lunch for PhD students 
WG3 Meeting: Intraluminal behavior of advanced formulations 
Chair: Prof. Caitriona O’Driscoll 
12:45 – 14:15 
The impact of excipient-bile interactions on the 
solubility of poorly-water soluble drugs 
Dr. Zahari Vinarov, Faculty of Chemistry and Pharmacy, 
Sofia University 
Oral protein delivery-learning from the TRANSINT 
EU Consortium 
Dr. Matilde Duran 
Update on current and future WG activities 
14:15 – 14:30 Coffee break 
WG4 Meeting: Food-drug interface 
Chair: Prof. Maura Corsetti 
14:30 – 16:00 
The utility of a pig model for predicting food 
dependent oral bioavailability in humans 
Dr. Brendan Griffin 
What do we know about the gut response to a meal 
in humans 
Prof. Maura Corsetti 
Update on current and future WG activities  
16:00 – 16:30 General discussion and meeting wrap up  Prof. Christos Reppas 
 
Ensuring the precision  
you need – every time
If timing is essential, our instant and modiﬁed release portfolio provides the necessary ﬁne 
mechanics for the precise setting of your products. Our functional solutions enable you to 
ensure exactly the right time and mode of action to reach the full potential of your APIs.  
With the perfect interaction of our technical expertise, exceptional quality and cutting-edge  
functionality of our excipients, we can make your products become a precisely functioning 
success with that all-important competitive advantage.
Instant & Modified Release | Solubilization | Skin Delivery | Softgels | Biologic Solutions
Follow us on Twitter: BASF_Pharma 
www.pharma.basf.com
Pharma Solutions. Focusing on your needs with platform solutions.
За повече информация относно продуктите, посетете www.metrohm.com
Метром България ЕООД, София, ул. Чипровци 12, тел. 02/953 40 64, office@metrohm.bg
Световен лидер в производството на 
прецизни инструменти за химически анализ
 Титруване: 
потенциометрично и Karl Fischer
 Волтаметрия
 Йонна хроматография
 рН, йон метри и кондуктометри
 Инструменти за измерване на стабилност
 NIR и RAMAN спектроскопия
 on-line анализатори
 Потенциостат / галваностати
Poster presentations at Vitosha Conference Hall 
13 
No. Firstname Lastname WG Poster title 
WG1: Differences between specific patient populations 
1 Marija Jovanovic WG1 Application of population pharmacokinetic modeling approach in the 
assessment of drug exposure in special patient populations 
2 Marton Kiss WG1 Drug dosing optimisation using pediatric intestinal tissue 
3 Malgorzata Sznitowska WG1 Oral paediatric antibiotics - the need for better pharmaceutical care 
4 Maiara Montanha WG1  Reduced oral bioavailability of Amoxicillin tablets compared to suspensions 
in RYGB bariatric subjects
5 Anna Stachowiak WG1 The assessment of the pharmacokinetics of tramadol and its active 
metabolite (O-desmethyltramadol) in extremely obese patients. 
6 Erik  Wollmer WG1 A novel patient-specific in vitro drug release model incorporating 
physiological features relevant to oral drug absorption in Parkinson 
patients 
7 Lisa Freerks WG1 A toolbox for simulating gastrointestinal conditions in children: I. Media to 
simulate typical paediatric breakfasts 
40 Maja Kristensen WG1 Application of microcontainers for targeting intestinal lesions found in 
inflammatory bowel disease  
Poster presentations at Vitosha Conference Hall 
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WG2: Regional differences along the gastrointestinal tract 
8 J. Arturo García-
Horsman 
WG2 Animal SPECT/CT and drug absorption. (Preliminary) 
9 Elena Toader WG2 Drug absorption and therapeutic implications in inflammatory bowel 
disease 
10 Sarinj Fattah WG2 Effect of a stimulated intestinal fluid on permeability of [3H]-octreotide 
across human and rat intestinal tissue 
11 Christian Jede WG2 Implementation of biorelevant bicarbonate buffer in a GI transfer model 
12 Fiona  McCartney WG2 Investigation of different intestinal permeation enhancers ex vivo and in 
vivo  
13 Mare Oja WG2 Logistic classification models for pH-permeability profile to improve 
prediction of absorption in gastrointestinal tract 
14 Khaled Heissam WG2 Measuring fasted state gastric motility before and after a standard BA/BE 
8 oz drink of water: validation of new MRI imaging protocols against 
concomitant perfused manometry in healthy participants  
15 Margherita Falavigna WG2 Mucus-PVPA: an in vitro permeability screening tool for the investigation 
of intestinal drug absorption 
Poster presentations at Vitosha Conference Hall 
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16 Glenn Lemmens WG2 Pharmacokinetic disposition of COXIBS for the prevention/treatment of 
colorectal cancer 
17 Marlies Braeckmans WG2 The influence of gastric motility on intraluminal drug behavior 
43 Natashia Larsen WG2 Achieving targeted release of freeze-dried probiotic strains by granulation, 
extrusion, spheronization and fluid bed coating 
WG3: Intraluminal behaviour of advanced formulations 
18 Caroline  Alvebratt  WG3 A Dissolution-Digestion-Permeation Assay to Investigate the Performance 
of Advanced Drug Delivery Systems 
19 Grzegorz Garbacz WG3 Bio-predictive dissolution testing of nicotinic acid 
20 Mette Sloth Bohsen WG3 Co-existing colloidal phases of human duodenal aspirates: Intraindividual 
fluctuations and interindividual variability in relation to molecular 
composition 
21 Vladimir  Katev WG3  Albendazole Solution Formulation via Vesicle-To-Micelle Transition of 
Phospholipid-Surfactant Aggregates
22 Ann-Christin Jacobsen WG3 High-throughput dissolution/permeation screening of enabling 
formulations: Testing a novel two-compartment microtiter plate approach 
23 Linas Petkevičius WG3 Mathematical modelling of drug release from multi-layer capsules 
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24 Niklas Koehl WG3 New insights into using lipid based suspensions for ‘brick dust’ molecules: 
case study of Nilotinib 
25 Jana  Kubackova     WG3 Oral delivery of oligonucleotides for local treatment of inflammatory bowel 
disease 
26 Gaohua Lu WG3 PBPK Application Examples 
27 Jadwiga Paszkowska WG3 Predictive dissolution testing - novel methodology 
28 Flavia  Laffleur WG3 Smart and advanced polymeric formulations  
29 Janneke  Keemink  WG3 The in vitro lipolysis-permeation assay predicts in vivo performance of 
carvedilol administered with lipids in dogs 
39 Jens Ceulemans WG3 Early development of a poorly-soluble oncology drug candidate: 
proceeding with a conventional or enabling formulation? 
44 Georgia Tsakiridou WG3 A simple rheological method for polymer selection in amorphous drug solid 
dispersions 
WG4: The food-drug interface 
30 Radić Kristina WG4 Comparison of different in vitro tools for prediction of intestinal 
permeability of olive derived nutraceuticals 
31 Annalisa  Maruca  WG4 Drug-food interactions evaluated by computational methods 
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33 Hulya  Buyukkestelli  WG4 Effect of food on oral drug absorption and bioavailability 
34 Raffaella  Catalano  WG4 Food-drug interactions evaluated by computational methods 
35 Tjaša  Felicijan WG4 Glass-bead flow through dissolution system: design and applicability 
36 Visnja Stepanic WG4 In silico predictions of ADME/Tox features of herbicides 
37 Simone Hansmann WG4 Integrating in vitro data into an in silico model to predict the influence of 
formulation changes: a Merck case example 
38 Aleksandar Cvetkovski WG4 Screening for nutraceutical-drug interactions toward the noncovalent 
interactions of their solid binary systems (Case study on Piperine) 
41 James Butler WG4 How effective are biopharmaceutics classification systems (BCS, DCS, 
BDDCS) at predicting food effects? 
42 Michael Grimm WG4 The application of MRI to study gastric emptying in the fed state 
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Transportation to and from Sofia Airport 
Inter-Terminal Transfer 
Sofia Airport provides free-of-charge 
transportation between Terminal 1 and 
Terminal 2 at every 30 minutes between 
07:00 and 19:00 local time, with no 
intermediate stops on the route. The 
shuttle bus stops in front of both 
terminals are indicated with signage and 
marking on the road pavement. 
Transportation from Terminal 2 to Park Hotel Vitosha via Metro 
 
The metro station at Sofia Airport is located 
in the eastern part of Terminal 2. You 
can reach it by following the floor markings 
in blue at the public area of Terminal 2. The 
nearest stop to your Hotel is GM Dimitrov, 
and after that you have a 15 min walk to the 
hotel. 
Transportation to Park Hotel Vitosha organized by the hotel 
Airport-to-hotel transfer is included in the room price for participants that 
have booked a room in hotel Vitosha by sending an e-mail to 
reservations@vitoshaparkhotel.com and have mentioned the booking 
reference "COST-UNGAP 11-13.02.2019” in the body text of the e-mail. 
Note that airport-to-hotel transfer will be provided only to participants who 
have sent their flight information to reservations@vitoshaparkhotel.com and 
have received official confirmation for the transfer from the hotel staff. 
 
Transportation 
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Getting to and from the airport by Taxi 
For your comfort and safety, we recommend the 
services of the taxi operator OK Supertrans AD as 
contractual partner of Sofia Airport. You can request 
the service at the offices of OK Supertrans in the 
Arrivals of Terminal 1 and Terminal 2. And the floor 
markings in yellow will lead you to the taxi stand area. 
+359 2 973 2121 
www.oktaxi.net 
IMPORTANT! 
We recommend that you do not use taxi services offered outside the 
office of the taxi operator or in front of the terminal to avoid the risk of 
abuse. 
When you are checking out of the Hotel and heading to the Airport, you can 
ask the Hotel Reception to call you a taxi. 
The cost of a Taxi should be under 15 Levs BGN (7.50 EUR) 1 EUR = 2 
Bulgarian Levs 
For more transportation options to and from the Airport, you can 
check: https://www.sofia-airport.bg/en/passenger 
 
Please note that the costs for transport by taxi are NOT REFUNDED 
by COST, unless in special circumstances (see COST Vademecum)
Sightseeing in Sofia 
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Sightseeing in Sofia 
The beginning of your tour of Sofia starts at the Metro station “Sofia University Kliment 
Ohridski”. You can go there by going to Metro station “GM Dimitrov” (see page 28) 
and getting on a train for “Obelya” for 3 stops. Also a Taxi is always an option, the 
cost should be under 10 BGN (5 EUR).  
When you get there the first thing you will see the main building of Sofia 
University.  
 
The University was founded in 1888 and was originally named after the brothers 
Evlogi and Hristo Georgiev who donated the land and funds for the construction of 
the university building. Their statues are seated outside the main entrance. The 
international design competition was originally won by Henri Breansson in 1907, his 
designs were however later modified by Yordan Milanov. Nowadays only part of the 
actual university campus is based here, with many faculties located around the city. 
1. Then you will head to Alexander Nevsky Cathedral  
Named after Alexander Nevski, a 
Russian Tsar who saved Russia from 
invading Swedish troops in 1240 and the 
patron saint of Tsar Alexander II, who 
was also referred to as Bulgaria’s Tsar 
Osvoboditel (Liberator), since it was his 
troops that finally brought about 
Bulgaria’s liberation from Ottoman rule. 
Some of Russia and Bulgaria’s best 
artists of the time worked on the interior 
with its five aisles and three altars. Built between 1904-1912 in the Neo Byzantine 
style, typical for Russian churches in the 19th century, the cathedral is 76 metres long 
and 53 metres wide and is said to hold up to 7000 people. The belfry is 52 metres 
high and houses 12 bells. Working hours: 7:00 – 18:00 
Sightseeing in Sofia 
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2. Your next stop is Tsar Osvoboditel (Liberator) Monument and the 
Parliament 
This fine bronze statue portrays the Russian 
Tsar Alexander II on horseback and is a 
gesture of gratitude to the Russian Tsar and 
his troops. In front of the bronze statue is the 
building of the National Assembly.  
 
 
 
3. On your way to Metro station “Serdika” you will pass through a 
couple of landmarks. 
The Russian Church  
This small decorative church with its golden 
onion domes was built between 1912 and 
1914, (by many of the same workers from the 
nearby Nevski Cathedral) to appease a 
Russian diplomat afraid to worship in 
Bulgarian churches. The church is named 
after St. Nikolai ‘the miracle maker’. To this 
day wishes are written on slips of paper and 
placed in the wooden box by the white marble 
sarcophagus of Bishop Serafim (1881 – 
1950), who is buried in the crypt. 
The Bulgarian Presidency 
Today the Bulgarian president has his 
official chambers here facing the 
archaeological museum and his guard 
of honor has been photographed by 
many a tourist. The guards change 
every hour on the hour but if you want 
the full pomp and ceremony be here on 
the first Wednesday of the month at 
12:00 when you can see the official 
changing of the guards complete with 
music, shouting and weapon 
brandishing. 
Sightseeing in Sofia 
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Complex Ancient Serdika 
The Church of St George is an Early 
Christian red brick rotunda that is 
considered the oldest building in Sofia, the 
capital of Bulgaria. It is situated behind the 
Sheraton Hotel, amid remains of the 
ancient town of Serdica. 
Built by the Romans in the 4th century, it is 
a cylindrical domed structure built on a 
square base. It is believed that it was built 
on the site of a pagan temple, though the 
original purpose of the building was for public use. The building is famous for the 
12th-, 13th- and 14th-century frescoes inside the central dome. Three layers of 
frescoes have been discovered, the earliest dating back to the 10th century. 
Magnificent frescoes of 22 prophets over 2 metres tall crown the dome. Painted over 
during the Ottoman period, when the building was used as a mosque, these frescoes 
were only uncovered and restored in the 20th century. 
Saint Sofia Statue 
Towering above the intersection of Maria Louisa Blvd and 
Todor Alexandrov Blvd in the commercial heart of the city, 
Sofia was erected in 2001 – not without some controversy 
– replacing Lenin’s monument, which was removed from 
the same spot at the time of the democratic changes. Eight 
meters in height, the copper and bronze statue by the 
sculptor Georgi Chapkanov, stands on a 16 meter high 
pedestal. Adorned with the symbols of power (crown), fame (wreath) and wisdom 
(owl), the crown is also a reference to the Goddess of Fate – Tjuhe, inspired by the 
old emblem of Sofia dating back to 1900.  
4. Your last stop on the tour is St. Kyriaki Church (St. Nedelya) 
From here you can explore the different cafes and restaurants on Vitosha 
Boulevard, which is the main pedestrian street in the heart of Sofia.  If you want to 
see more of Sofia, at the end of Vitosha Boulevard there is a park across the street 
in which you can find the National Palace of Culture.  
To go back to the Hotel you can get a Metro from Serdica Station Line 1 to Mladost, 
your stop is the 4th – GM Dimitrov Station. 
Sightseeing in Sofia 
23 
 
 
To get a Metro from the National Palace of Culture, go to NDK station, which is at 
the intersection where you crossed from boulevard Vitosha to the park, and get a 
train to Obelya for one stop (Serdica Station), this is Line 2 of the Metro, so you will 
have to transfer to Line 1 and get a train to Mladost for four stops to GM Dimitrov 
Station. 
The price of the Metro is 1.60 Levs, tickets can be bought at the vending 
machines at every entrance or at the cashiers boot next to the barriers. Also you 
can buy a daily pass from the cashier for 4 Levs. 
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No. Last name First name E-mail Affiliation Country 
1 Alsenz Jochem Jochem.Alsenz@roche.com F. Hoffmann-La Roche AG Switzerland 
2 Alvebratt Caroline caroline.alvebratt@farmaci.uu.se Uppsala University Sweden 
3 Augustijns Patrick patrick.augustijns@kuleuven.be University of Leuven Belgium 
4 Batchelor Hannah h.k.batchelor@bham.ac.uk University of Birmingham UK 
5 Beloqui Garcia Ana ana.beloqui@uclouvain.be University of Leuven Belgium 
6 Bermejo Sanz Maria del Val mbermejo@goumh.umh.es  
Universidad Miguel 
Hernandez Spain 
7 Bogataj Marija marija.bogataj@ffa.uni-lj.si University of Ljubljana Slovenia 
8 Bogdanova Svetla svbogdanova@gmail.com Sofia University Bulgaria 
9 Bohsen Mette Sloth bohsen@sdu.dk 
University of Southern 
Denmark Denmark 
10 Boltnarová Barbora boltnarb@faf.cuni.cz Charles University Czech Republic 
11 Braeckmans Marlies marlies.braeckmans@kuleuven.be University of Leuven Belgium 
12 Brandl Martin mmb@sdu.dk 
University of Southern 
Denmark Denmark 
13 Butler James james.m.butler@gsk.com GlaxoSmithKline UK 
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University Magna Graecia 
of Catanzaro Italy 
15 Ceulemans Jens  jceulem3@its.jnj.com Janssen Pharmaceutica Belgium 
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17 Corsetti Maura maura.corsetti@nottingham.ac.uk University of Nottingham UK 
18 Cvetkovski Aleksandar aleksandar.cvetkovski@ugd.edu.mk Goce Delcev University Macedonia, FYR 
19 Dahlgren David david.dahlgren@farmaci.uu.se Uppsala University Sweden 
20 De Wildt Saskia Saskia.deWildt@radboudumc.nl Radboud UMC The Netherlands 
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